These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31279847)

  • 1. Compliance with cervical cancer screening guidelines in young female patients: rates and trends of screening in New Haven County, CT.
    Oliveira CR; Hosier H; Pate B; Niccolai LM; Sheth SS; Vash-Margita A
    Am J Obstet Gynecol; 2019 Nov; 221(5):530-532. PubMed ID: 31279847
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renewal of the National Cervical Screening Program.
    Carter J
    Med J Aust; 2016 Oct; 205(8):357-358. PubMed ID: 27736622
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States.
    Chido-Amajuoyi OG; Shete S
    Am J Obstet Gynecol; 2019 Jul; 221(1):75-77. PubMed ID: 31078510
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical Cancer Screening Guideline for Individuals at Average Risk.
    Chor J; Davis AM; Rusiecki JM
    JAMA; 2021 Dec; 326(21):2193-2194. PubMed ID: 34766970
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening with Papanicolaou tests in Alberta: Are we Choosing Wisely?
    Symonds CJ; Chen W; Rose MS; Cooke LJ
    Can Fam Physician; 2018 Jan; 64(1):47-53. PubMed ID: 29358254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 9. Cervical cancer screening among vulnerable women: factors affecting guideline adherence at a community health centre in Toronto, Ont.
    Wiedmeyer ML; Lofters A; Rashid M
    Can Fam Physician; 2012 Sep; 58(9):e521-6. PubMed ID: 22972744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for the implementation of cervical cancer screening and human papillomavirus vaccination in the ED: a pilot study.
    Devine AS; Mason J; Rankins N; Favor TT; Baur V; Parker R; Baddorf S; McCarthy M; Ford L; Cunningham TD
    Am J Emerg Med; 2016 Mar; 34(3):648. PubMed ID: 26851060
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversies in cervical cancer screening.
    Schorge JO
    Clin Obstet Gynecol; 2013 Mar; 56(1):1-2. PubMed ID: 23318572
    [No Abstract]   [Full Text] [Related]  

  • 12. New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    Slomski A
    JAMA; 2020 Nov; 324(20):2017-2018. PubMed ID: 33156325
    [No Abstract]   [Full Text] [Related]  

  • 13. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 14. Do it yourself cervical cancer test: A gateway to increase cervical cancer screening in Pakistan.
    Baig E; Furqan A; Abid M
    J Pak Med Assoc; 2023 Apr; 73(4):955. PubMed ID: 37052033
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Controversies in Cervical Cancer Screening.
    Bus-Kwofie A; Chan C; Kahn R; Holcomb K
    Clin Obstet Gynecol; 2019 Dec; 62(4):644-655. PubMed ID: 31305485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future trends in cervical cancer screening.
    Castle P; Dowdall M
    Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system.
    Becerra-Culqui TA; Lonky NM; Chen Q; Chao CR
    Am J Obstet Gynecol; 2018 Apr; 218(4):429.e1-429.e9. PubMed ID: 29277629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and cervical screening: misconceptions undermine adherence.
    Panagopoulou E; Giata O; Montgomery A; Dinas K; Benos A
    Am J Health Promot; 2011; 26(1):6-9. PubMed ID: 21879936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Absolute and Comparative Risk Perceptions on Cervical Cancer Screening and the Mediating Role of Cancer Worry.
    Zhao X; Nan X
    J Health Commun; 2016; 21(1):100-8. PubMed ID: 26312444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.